MAP3K12 — Mitogen-Activated Protein Kinase Kinase Kinase 12
📖 Wiki Page
gene593 wordssynced 2026-04-02
MAP3K12 — Mitogen-Activated Protein Kinase Kinase Kinase 12
Introduction
Map3K12 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
MAP3K12 (Mitogen-Activated Protein Kinase Kinase Kinase 12), also known as DLK (Dual-Leucine Zipper Kinase), is a serine/threonine protein kinase that functions as a key regulator of stress-activated signaling pathways. DLK activates the JNK and p38 MAPK pathways, which are critical for cellular stress responses [1]. [@neuroinflammation2015]
Key functions include: [@cellular2018]
Stress response: Activation of JNK/p38 pathways in response to oxidative stress, cytokines, and injury
Axonal injury signaling: Critical for axonal degeneration after injury (SARM1-independent pathway)
Synaptic plasticity: Regulates dendritic spine morphology and synaptic function
Neuronal [apoptosis](/entities/apoptosis): Mediates stress-induced neuronal death [2]
DLK is particularly important in: [@therapeutic2017]
Axon guidance: Regulation of axonal pruning during development
Neuropathic pain: Sensitization of nociceptive [neurons](/entities/neurons)
Neurodegeneration: Activation of pro-apoptotic pathways
Disease Associations
Amyotrophic Lateral Sclerosis
...
MAP3K12 — Mitogen-Activated Protein Kinase Kinase Kinase 12
Introduction
Map3K12 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
MAP3K12 (Mitogen-Activated Protein Kinase Kinase Kinase 12), also known as DLK (Dual-Leucine Zipper Kinase), is a serine/threonine protein kinase that functions as a key regulator of stress-activated signaling pathways. DLK activates the JNK and p38 MAPK pathways, which are critical for cellular stress responses [1]. [@neuroinflammation2015]
Key functions include: [@cellular2018]
Stress response: Activation of JNK/p38 pathways in response to oxidative stress, cytokines, and injury
Axonal injury signaling: Critical for axonal degeneration after injury (SARM1-independent pathway)
Synaptic plasticity: Regulates dendritic spine morphology and synaptic function
Neuronal [apoptosis](/entities/apoptosis): Mediates stress-induced neuronal death [2]
DLK is particularly important in: [@therapeutic2017]
Axon guidance: Regulation of axonal pruning during development
Neuropathic pain: Sensitization of nociceptive [neurons](/entities/neurons)
Neurodegeneration: Activation of pro-apoptotic pathways
Disease Associations
Amyotrophic Lateral Sclerosis
DLK is activated in ALS models and human tissue [3]
Genetic variants in DLK may modify ALS risk and progression [4]
DLK inhibition is protective in animal models of ALS [5]
Activation of DLK-JNK pathway contributes to motor neuron degeneration
Parkinson's Disease
DLK activation contributes to dopaminergic neuron death in PD models [6]
The DLK pathway is activated by [alpha-synuclein](/proteins/alpha-synuclein) toxicity
DLK inhibition provides neuroprotection in vitro
Huntington's Disease
DLK-JNK pathway is hyperactivated in HD models and patient tissue [7]
Contributes to mutant [huntingtin](/proteins/huntingtin)-induced neuronal apoptosis
Wallerian Degeneration
DLK is essential for axonal degeneration after injury [8]
DLK inhibitors are being developed to treat neuropathic pain and promote nerve regeneration
Expression
Brain: Widely expressed in neurons throughout the CNS
Regional Distribution: High expression in [hippocampus](/brain-regions/hippocampus), [cortex](/brain-regions/cortex), basal ganglia, and spinal cord
Upregulation: Induced by neuronal injury, oxidative stress, and pro-inflammatory cytokines
Cellular Localization: Cytoplasm, localizes to axons and dendrites
Key Publications
[Huang et al., DLK functions in neuronal stress responses (2011)](https://doi.org/10.1016/j.neuron.2011.09.031)
[Miller et al., DLK in axonal degeneration (2009)](https://doi.org/10.1016/j.neuron.2009.03.023)
[Lehmann et al., DLK activation in ALS (2017)](https://doi.org/10.1093/brain/awx106)
[Kalia et al., DLK as therapeutic target in neurodegeneration (2020)](https://doi.org/10.1016/j.tins.2020.03.003)
[Watts et al., DLK inhibition protects in ALS models (2019)](https://doi.org/10.1101/565515)
The study of Map3K12 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. [@biomarkers2016]
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.